| Not Yet Recruiting | To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence an NCT06315270 | The First Hospital of Jilin University | — |
| Recruiting | Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube C NCT05659381 | GOG Foundation | Phase 3 |
| Recruiting | Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian NCT05961124 | Sunnybrook Health Sciences Centre | Phase 2 |
| Recruiting | A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) NCT05429970 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | Ask Questions (ASQ):Implementation of a Communication Intervention NCT05025748 | Barbara Ann Karmanos Cancer Institute | N/A |
| Recruiting | Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With A NCT04811703 | Hospices Civils de Lyon | Phase 1 |
| Active Not Recruiting | Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy NCT04204811 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | 18F-DCFPyL PET/CT in High-grade Epithelial Ovarian Cancer (PET HOC) NCT03811899 | University Health Network, Toronto | N/A |
| Completed | Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian C NCT03297489 | Roswell Park Cancer Institute | EARLY_Phase 1 |
| Completed | Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer NCT03154190 | Stanford University | N/A |
| Terminated | IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, o NCT03029611 | University of Washington | Phase 2 |
| Completed | Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors NCT03198286 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | N/A |
| Terminated | Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis NCT02441140 | Dana-Farber Cancer Institute | N/A |
| Completed | Ovarian Cancer Patient-Centered Decision Aid NCT02259699 | University of California, Irvine | N/A |
| Active Not Recruiting | HOT: HIPEC in Ovarian Cancer as Initial Treatment NCT02124421 | Mercy Medical Center | Phase 2 |
| Completed | Salvage Ovarian FANG™ Vaccine + Carboplatinum NCT01867086 | Gradalis, Inc. | Phase 2 |
| Completed | Interactive Educational Website for Women With Ovarian Cancer & Caregivers NCT01626014 | University of Minnesota | EARLY_Phase 1 |
| Unknown | Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer NCT01650376 | Swedish Medical Center | Phase 1 / Phase 2 |
| Completed | Salvage Ovarian FANG™ Vaccine + Bevacizumab NCT01551745 | Gradalis, Inc. | Phase 2 |
| Completed | Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stag NCT01196429 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithe NCT00814086 | Gynecologic Oncology Group | Phase 1 |
| Withdrawn | Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial NCT00551265 | Gynecologic Oncology Group | N/A |
| Completed | Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopi NCT00301756 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, NCT00352300 | Gynecologic Oncology Group | Phase 1 |
| Completed | Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ova NCT00066456 | Gynecologic Oncology Group | Phase 1 |
| Completed | Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopia NCT00060359 | Gynecologic Oncology Group | Phase 1 |
| Completed | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary NCT00011986 | Gynecologic Oncology Group | Phase 3 |
| Terminated | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian NCT00004221 | Gynecologic Oncology Group | Phase 2 |
| Terminated | Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer NCT00003532 | Burzynski Research Institute | Phase 2 |